Formulation of a recombinant HIV‐1 polytope candidate vaccine with naloxone/alum mixture: induction of multi‐cytokine responses with a higher regulatory mechanism-Reference-Cited by-同舟云学术

Formulation of a recombinant HIV‐1 polytope candidate vaccine with naloxone/alum mixture: induction of multi‐cytokine responses with a higher regulatory mechanism

Published:2021-06-11 Issue:8 Volume:129 Page:480-488
ISSN:0903-4641
Container-title:APMIS
language:en
Short-container-title:APMIS

Author:

Fathi Meimanat¹²³,Nezamzadeh Reza²,Abdollahpour‐Alitappeh Meghdad⁴,Yazdi Mohammad Hossein⁵⁶,Khoramabadi Nima⁷,Mahdavi Mehdi¹⁶⁸

Affiliation:

1. Recombinant Vaccine Research Center Faculty of Pharmacy Tehran University of Medical Sciences TehranIran

2. Department of Genetic Islamic Azad University, Damghan Branch Damghan Iran

3. Department of Cell techniques and Applied Stem Cell Biology Center for Biotechnology and Biomedicine (BBZ) Faculty of Medicine University of Leipzig Leipzig Germany

4. Cellular and Molecular Biology Research Center Larestan University of Medical Sciences LarestanIran

5. Biotechnology Research Center Faculty of Pharmacy Tehran University of Medical Sciences TehranIran

6. Pharmaceutical Sciences Research Center (PSRC) The Institute of Pharmaceutical Sciences (TIPS) Tehran University of Medical Sciences TehranIran

7. Department of Bacteriology Faculty of Medical Sciences Tarbiat Modares University TehranIran

8. Department of Immunology Pasteur Institute of Iran Tehran Iran

Publisher

Wiley

Subject

Microbiology (medical),General Medicine,Immunology and Allergy,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apm.13122

Reference39 articles.

1. ELISPOT analysis of a new CTL based DNA vaccine for HIV-1 using GM-CSF in DNA prime/peptide boost strategy: GM-CSF induced long-lived memory responses

2. Biodegradable Nanoparticles as Vaccine Adjuvants and Delivery Systems: Regulation of Immune Responses by Nanoparticle-Based Vaccine

3. Combination of adjuvants: the future of vaccine design

4. Alum's adjuvant action: grease is the word

5. Aluminum Vaccine Adjuvants: Are they Safe?

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of Immunostimulatory Effects of IFN‐γ Cytokine and CD40 Ligand Costimulatory Molecule for Development of HIV‐1 Therapeutic Vaccine Candidate;Advanced Biology;2023-10-15

2. Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses;Viral Immunology;2023-08-01

3. Different Formulations of Inactivated SARS-CoV-2 Vaccine Candidates in Human Compatible Adjuvants: Potency Studies in Mice Showed Different Platforms of Immune Responses;Viral Immunology;2022-12-01

4. Montanide ISA-720 and Naloxone in HBsAg Vaccine Formulation: Cytokine Profiling and Monitoring of Long-Lasting Humoral Immune Responses*;BIOMED ENVIRON SCI;2022

5. Improvement of the inactivated SARS-CoV-2 vaccine potency through formulation in alum/naloxone adjuvant; Robust T cell and anti-RBD IgG responses;IRAN J BASIC MED SCI;2022